A.H. Honkoop

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer

A.H. Honkoop, PJ van Diest, JS de Jong et al. · British Journal of Cancer · 1998 · 185 citations · Full text

Medicine, Oncology, Pathology +16

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer

S. C. Linn, A.H. Honkoop, Klaas Hoekman et al. · British Journal of Cancer · 1996 · 109 citations · Full text

Medicine, Molecular Biology, Oncology +10

Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial

Jorine H. Savonije, C.J. van Groeningen, Aart van Bochove et al. · European Journal of Cancer · 2005 · 42 citations

Medicine, Hematology, Oncology +15

Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study

Miriam Koopman, Ninja Antonini, J. Douma et al. · Annals of Oncology · 2006 · 39 citations · Full text

Medicine, Oncology, Pharmacology +16

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial

Siu W. Lam, S.M. de Groot, A.H. Honkoop et al. · European Journal of Cancer · 2014 · 31 citations

Medicine, Oncology, Pharmacology +16